About Us
Conditions & Procedures
Conditions
Procedures
Faculty
Education & Training
Patient Center
Life Clinic
Research
News
Message from the Chief
Hanmin Lee,
M.D.
Associate Professor & Chief, Division of Pediatric
Surgery
Director, Fetal Treatment Center
Dr. Michael Harrison Endowment Fund
Make a gift to the Endowed Chair in Fetal Treatment . This chair supports innovative research and the training of future fetal interventionalists.
Make a Gift
A gift to Pediatric Surgery helps provide surgical care for fetuses, infants, children, and adolescents.
In Memoriam
Dr. Alfred de Lorimier, a pioneer in pediatric surgery and the founder of the Division of Pediatric Surgery at UCSF, has passed away.
Michael R. Harrison, M.D.
Director Emeritus, Fetal Treatment Center
Division of Pediatric Surgery
Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology and Reproductive Sciences
Contact Information
Campus Box 0570
University of California, San Francisco
513 Parnassus Avenue
San Francisco, CA 94143-0570
415-476-2538 Office
415-476-2929 Fax
pedsurg@surgery.ucsf.edu
BiographyEducation
- 1961-65, Yale University, B.A.
- 1965-69, Harvard Medical School, M.D., Medicine
Residencies
- 1969-71, Massachusetts General Hospital, Resident, Surgery
- 1973-74, Massachusetts General Hospital, Senior Resident, Surgery
- 1974-75, Massachusetts General Hospital, Chief Resident, Surgery
Fellowships
- 1971-73, Laboratory of Immunology, National Institute of Allergy and Infectious Disease, Fellow, Allergy & Immunology (Peds)
- 1975-76, Rikshospitalet, Fellow, Pediatric Surgery
- 1976-78, Children's Hospital of Los Angeles, Fellow, Pediatric Surgery
Board Certification
- American Board of Surgery, 1978, renewed 1988
- American Board of Surgery, Special Competence in Pediatric Surgery, 1979, renewed 1989
- American Board of Surgery, Surgical Critical Care, 1991
Program Affiliations
- Fetal Treatment Center
Clinical Expertise
- Birth Defects
- Congenital Diaphragmatic Hernia (CDH)
- Fetal Surgery
- Minimally Invasive Surgery
- Pediatric Surgery
Research Interests
- Developmental Biology
- Hematopoietic Stem Cells
- Pectus Excavatum Repair
- World Health
- Birth Defects
- Minimally Invastive Surgery
Website Links
Biography
Dr. Michael Harrison is Professor Emeritus of Surgery and Pediatrics and the Director Emeritus of the Fetal Treatment Center at UCSF. He graduated cum laude from Yale University and magna cum laude from Harvard Medical School. He completed his surgical training at the Massachusetts General Hospital in Boston and his pediatric surgery fellowship at Children's Hospital of Los Angeles. He is board certified in Surgery, Pediatric Surgery, and Critical Care.
Dr. Harrison and his surgery associates confine their surgical practice exclusively to children with special interest in fetal surgery, in repair of complex birth defects involving the chest, lung, abdomen, bowel, and bladder, and surgical care of children from birth through adolescence. Dr. Harrison and his associates, The Bay Area Pediatric Surgeons, do consultations and provide surgical care at Moffitt/Long Hospitals UCSF, California Pacific Medical Center, and Kaiser Permanente, San Francisco.
Dr. Harrison has a special interest in fetal surgery which he has pioneered with his colleagues at UCSF. For the past 18 years Dr. Harrison has studied the pathophysiology and natural history of a number of life-threatening fetal abnormalities including congenital diaphragmatic hernia, congenital cystic adenomatoid malformation of the lung, sacrococcygeal teratoma, fetal obstructive uropathy, and myelomeningocele. He has developed techniques for both in-utero open fetal surgery and endoscopic surgical repair (FETENDO Fetal Surgery)of many fetal abnormalities. In addition, Dr. Harrison's team has developed in-utero stem cell transplantation to treat immunodeficiencies, enzyme deficiencies, and hemoglobinopathies. Dr. Harrison leads the multidisciplinary UCSF Fetal Treatment Center Team that has developed an international reputation for treating complex birth defects before and after birth. (Referrals can be made to 1-800-RX-FETUS.)
Dr. Harrison, his wife Gretchen, and four children have lived in San Francisco for the past 20 years.
Selected Publications
- Clifton MS, Harrison MR, Ball R, Lee H.
Fetoscopic Transuterine Release of Posterior Urethral Valves: A New Technique.
Fetal Diagn Ther. 2007 Nov 23;23(2):81-86 - Gillis AM, Sutton E, Dewitt KD, Matthay KK, Weinberg V, Fisch
BM, Chan A,
Gooding C, Daldrup-Link H, Wara WM, Farmer DL, Harrison MR, Haas-Kogan D.
Long-term outcome and toxicities of intraoperative radiotherapy for high-risk
neuroblastoma.
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):858-64. Epub 2007 May 22. - Crombleholme TM, Shera D, Lee H, Johnson M, D'Alton M, Porter
F, Chyu J,
Silver R, Abuhamad A, Saade G, Shields L, Kauffman D, Stone J, Albanese CT,
Bahado-Singh R, Ball RH, Bilaniuk L, Coleman B, Farmer D, Feldstein V, Harrison
MR, Hedrick H, Livingston J, Lorenz RP, Miller DA, Norton ME, Polzin WJ, Robinson
JN, Rychik J, Sandberg PL, Seri I, Simon E, Simpson LL, Yedigarova L, Wilson RD,
Young B.
A prospective, randomized, multicenter trial of amnioreduction vs selective
fetoscopic laser photocoagulation for the treatment of severe twin-twin
transfusion syndrome.
Am J Obstet Gynecol. 2007 Oct;197(4):396.e1-9. - Ozgediz D, Roayaie K, Lee H, Nobuhara KK, Farmer DL, Bratton B,
Harrison MR.
Subcutaneous endoscopically assisted ligation (SEAL) of the internal ring for
repair of inguinal hernias in children: report of a new technique and early
results.
Surg Endosc. 2007 Aug;21(8):1327-31. Epub 2007 Mar 14. - Yang SH, Nobuhara KK, Keller RL, Ball RH, Goldstein RB,
Feldstein VA, Callen
PW, Filly RA, Farmer DL, Harrison MR, Lee H.
Reliability of the lung-to-head ratio as a predictor of outcome in fetuses with
isolated left congenital diaphragmatic hernia at gestation outside 24-26 weeks.
Am J Obstet Gynecol. 2007 Jul;197(1):30.e1-7.
In the News
Surgeons Seek Kid-Sized Tools for the Operating Room
KQED Quest - Jan 27, 2012UCSF has received about a million dollars since 2009. That money has supported the development of tools to treat scoliosis, kidney failure and sunken chest, among other conditions. The pectus, or sunken chest device, is in clinical trials.
UCSF Consortium Collaborates to Invent Medical Devices for Children
UCSF News - Nov 01, 2011The UCSF "D'Vice Squad," a group of innovators from across the Bay Area, has drawn from diverse disciplines over the last two years to develop medical devices for children.
Now the squad's hard work has been rewarded with a $1 million grant from the U.S. Food and Drug Administration (FDA) to expand its work over the next two years.
Spina Bifida Study a "Huge Gamechanger for Fetal Surgery"
New York Times - Feb 09, 2011For years, surgeons have been seeking ways of operating on babies in the womb, reasoning that medical abnormalities are easier to address while the fetus is still developing. Now, for the first time, a large clinical trial has shown that fetal surgery can also benefit infants with non life-threatening conditions. The eight-year study, led by Dr. Diana Farmer, Chief of the Division of Pediatric Surgery at UCSF, reported in the New England Journal of Medicine, found that babies born with myelomeningocele, the most common form of spina bifida, a debilitating spinal abnormality, were twice as likely to walk and experienced fewer neurological problems with in utero repair versus standard post-natal repair. Dr. Farmer characterized it as a " huge game-changer for fetal surgery". Dr. Michael Harrison, who pioneered fetal surgery at UCSF, was a principal investigator on the trial before retiring.
Institute for Fetal and Neonatal Health 1st Annual Research Symposium
UCSF Pediatric Surgery - Nov 02, 2010UCSF announces the formation of the Institute for Fetal and Neonatal Health symposium brings together clinicians and basic scientists involved in different aspects of development and fetal intervention.
Treating scoliosis in kids with magnets
Smartplanet - Aug 17, 2010Stopping curvature of the spine in kids usually requires a series of painful operations to implant rods and screws to adjust the spine. Even then, the results are often less than perfect. However, a medical team at UCSF has developed a technique using magnets that promises to do away with so many surgeries.
Magnet Therapy Corrects South Bay Boy's Birth Defect
CBS5 - Apr 07, 2010Magnets have a brand new use. They are being tested in a new procedure to correct a rare birth defect , Pectus Excavatum, in a Los Gatos boy. Dr. Kim Mulvihill reports.
Harrison Endowment Receives Matching Grant
UCSF - Nov 19, 2009In our efforts to establish a distinguished professorship in honor of Michael R. Harrison, M.D, an extremely generous donor has called for a challenge. The anonymous donor has pledged a gift of $500,000 in the form of a match. Our goal must be met by Dec 31, 2009.
Michael Harrison M.D. Elected to Institute of Medicine
UCSF News - Oct 12, 2009Michael Harrison M.D., a renowned pioneer in fetal and pediatric surgery, Professor Emeritus of Surgery and Pediatrics, and Director Emeritus of the Fetal Treatment Center at UCSF, has been elected to the prestigious Institute of Medicine (IOM), one of the U.S. National Academies. Membership in the IOM reflects "the height of professional achievement and commitment to service" and is reserved for those at the pinnacle of their field.
Michael Harrison, M.D. Wins FDA Device Grant
San Francisco Business Times - Sep 21, 2009Dr. Michael Harrison of UCSF has won a $500,000 FDA grant - one of three awarded nationally - to develop a medical device for children.
UCSF researcher wins FDA device grant (SF Business Times)
Ad Campaign Raises Awareness of UCSF Medical Center’s Innovation
UCSF Today, CA - Jan 15, 2008Dr. Harrison helped change the face of medicine. Today, UCSF is building a medical complex where scientific innovations become life-saving treatments ...
Novel magnet treatment used to correct sunken chest
ABC7News.com - Nov 08, 2007UCSF has created a groundbreaking new procedure to treat chest deformities in children and teens. This minimally invasive procedure is already transforming one 14-year-old's life.
